Learn More
Apexbio Technology LLC GZD824, 25mg. Cas: 1421783-64-3 MFCD: MFCD26142656. Bcr-Abl inhibitor,novel orally bioavailable

Supplier: Apexbio Technology LLC B140225
GZD824 is an orally bioavailable inhibitor of Bcr-Abl with IC50 values of 0.34 and 0.68 nM for Bcr-AblWT and Bcr-AblT315I, respectively [1]. Bcr-Abl is a fused protein that interacts with the interleukin-3 receptor(c) subunit and has tyrosine kinase activity. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.